Mar 13, 2023 ProMIS Neurosciences Announces Abstracts Accepted for Presentation at the American Academy of Neurology 2023 Annual Meeting
Nov 14, 2022 ProMIS Neurosciences Announces Third Quarter 2022 Financial Results and Recent Highlights
Sep 13, 2022 ProMIS Neurosciences appoints accomplished biopharmaceutical leader, Dr. Gail M. Farfel, as Chief Executive Officer
Jul 27, 2022 ProMIS Neurosciences to Present at 2022 Alzheimer’s Association International Conference